Insights on Clinical Trials

31. Site Networks And Hybrid Solutions 7/22/2025

    Learn how community- and patient-centric site networks that have DCT capabilities are able to work with a broad-range of site types.

32. In-Vivo CAR Therapies — Global Research And Development Landscape 7/15/2025

    Delve into the evolving in-vivo CAR therapy landscape, examining key technological innovations, major industry players, recent clinical progress, and regulatory developments.

33. 4 Centralized Comparator Sourcing Models To Fortify Supply Chains 7/15/2025

    A team at Novartis developed models to address the often-overlooked challenge of clinical trial comparator sourcing, a weak link that can derail trials.

34. How To Build Effective Clinical Trial Oversight And Leadership 7/14/2025

    In a collaborative outsourcing model, the sponsor maintains direct contact with functional leads, eliminating communication gaps and enabling faster, better-informed decision-making.

35. Writing Effective Clinical Regulatory Documents For Therapy Trials 7/11/2025

    Clinical medical writing for gene therapy regulatory documents is a demanding, detail-oriented task that diverges significantly from medical writing for more traditional therapies.

36. Adaptive By Nature: Modern Tools For Modern Trial Designs 7/10/2025

    Adaptive platform trials (APTs) are reshaping clinical research by enabling multiple therapies to be tested simultaneously under a single, flexible protocol.

37. New EDC Tools Enable Even Faster Self-Serve Study Builds 7/10/2025

    Explore a powerful yet accessible EDC solution that enables faster, more efficient study builds without compromising data integrity or compliance, allowing clinical teams to focus on advancing research outcomes.

38. Streamline Recruitment With Confidence 7/10/2025

    Transform your clinical trial recruitment with a service that delivers faster, more cost-effective enrollment, particularly for hard-to-reach populations.

39. Immunology's Next Frontier: High-Risk, High-Reward Innovations From EULAR 2025 7/10/2025

    The 2025 European Congress of Rheumatology (EULAR) showcased a shift in immunology, highlighting a convergence of next-generation mechanisms and novel therapeutic modalities. Of note is the emergence of cell therapies as a treatment strategy.

40. Leveraging Biomarkers In Early PK/PD Studies To Drive Smarter Drug Development 7/9/2025

    Integrating biomarkers into early clinical studies is crucial to determine whether a new therapy engages its biological target, triggers the intended PD effects, and shows early signs of efficacy.